These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 8666891)

  • 1. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.
    Bevec T; Stoka V; Pungercic G; Dolenc I; Turk V
    J Exp Med; 1996 Apr; 183(4):1331-8. PubMed ID: 8666891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fragment of the major histocompatibility complex class II-associated p41 invariant chain inhibits cruzipain, the major cysteine proteinase from Trypanosoma cruzi.
    Bevec T; Stoka V; Pungercic G; Cazzulo JJ; Turk V
    FEBS Lett; 1997 Jan; 401(2-3):259-61. PubMed ID: 9013899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.
    Fineschi B; Sakaguchi K; Appella E; Miller J
    J Immunol; 1996 Oct; 157(8):3211-5. PubMed ID: 8871612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.
    Mihelic M; Dobersek A; Guncar G; Turk D
    J Biol Chem; 2008 May; 283(21):14453-60. PubMed ID: 18362148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S.
    Guncar G; Pungercic G; Klemencic I; Turk V; Turk D
    EMBO J; 1999 Feb; 18(4):793-803. PubMed ID: 10022822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous Thyropin from p41 Invariant Chain Diminishes Cysteine Protease Activity and Affects IL-12 Secretion during Maturation of Human Dendritic Cells.
    Zavašnik-Bergant T; Bergant Marušič M
    PLoS One; 2016; 11(3):e0150815. PubMed ID: 26960148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical localisation of cathepsin S, cathepsin L and MHC class II-associated p41 isoform of invariant chain in human lymph node tissue.
    Zavasnik-Bergant V; Sekirnik A; Golouh R; Turk V; Kos J
    Biol Chem; 2001 May; 382(5):799-804. PubMed ID: 11517933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p41 fragment story.
    Turk D; Guncar G; Turk V
    IUBMB Life; 1999 Jul; 48(1):7-12. PubMed ID: 10791909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.
    Shi GP; Bryant RA; Riese R; Verhelst S; Driessen C; Li Z; Bromme D; Ploegh HL; Chapman HA
    J Exp Med; 2000 Apr; 191(7):1177-86. PubMed ID: 10748235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p41 isoform of invariant chain is a chaperone for cathepsin L.
    Lennon-Duménil AM; Roberts RA; Valentijn K; Driessen C; Overkleeft HS; Erickson A; Peters PJ; Bikoff E; Ploegh HL; Wolf Bryant P
    EMBO J; 2001 Aug; 20(15):4055-64. PubMed ID: 11483509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equistatin, a new inhibitor of cysteine proteinases from Actinia equina, is structurally related to thyroglobulin type-1 domain.
    Lenarcic B; Ritonja A; Strukelj B; Turk B; Turk V
    J Biol Chem; 1997 May; 272(21):13899-903. PubMed ID: 9153250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cathepsin L monoclonal antibodies that distinguish cathepsin L from cathepsin V.
    Kopitar-Jerala N; Bevec T; Barlic-Maganja D; Gubensek F; Turk V
    Biol Chem; 2001 May; 382(5):867-70. PubMed ID: 11517943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing.
    Manoury B; Gregory WF; Maizels RM; Watts C
    Curr Biol; 2001 Mar; 11(6):447-51. PubMed ID: 11301256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal cysteine proteases and antigen presentation.
    Rudensky A; Beers C
    Ernst Schering Res Found Workshop; 2006; (56):81-95. PubMed ID: 16329647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodes.
    Zavasnik-Bergant V; Schweiger A; Bevec T; Golouh R; Turk V; Kos J
    Immunology; 2004 Jul; 112(3):378-85. PubMed ID: 15196205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invariant chain processing is independent of cathepsin variation between primary human B cells/dendritic cells and B-lymphoblastoid cells.
    Reich M; Zou F; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T
    Cell Immunol; 2011; 269(2):96-103. PubMed ID: 21543057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
    Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
    J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.
    Lalmanach G; Serveau C; Brillard-Bourdet M; Chagas JR; Mayer R; Juliano L; Gauthier F
    J Protein Chem; 1995 Nov; 14(8):645-53. PubMed ID: 8747425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and NMR structure of p41icf, a potent inhibitor of human cathepsin L.
    Chiva C; Barthe P; Codina A; Gairí M; Molina F; Granier C; Pugnière M; Inui T; Nishio H; Nishiuchi Y; Kimura T; Sakakibara S; Albericio F; Giralt E
    J Am Chem Soc; 2003 Feb; 125(6):1508-17. PubMed ID: 12568610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L.
    Bocock JP; Edgell CJ; Marr HS; Erickson AH
    Eur J Biochem; 2003 Oct; 270(19):4008-15. PubMed ID: 14511383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.